Veru Inc. With a strong focus on oncology, Veru is committed to finding alternative treatment approaches for breast cancer, including IV chemotherapy, as well as addressing the pressing needs in women's sexual and reproductive health through their Urev program. In addition to their work in oncology, Veru is also dedicated to tackling viral ARDS-related infectious diseases, such as SARS-CoV-2, through their research on microtubule trafficking networks.

By targeting both the virus infection and the inflammatory response, they aim to combat viral infections that pose serious global health threats. Led by an experienced management team, including Chairman and CEO Mitchell Steiner, M. D., F.

A. C. S., and Vice Chairman and Chief Corporate Officer Harry Fisch, M.

D., F. A. C.

S., Veru Inc